BGACF Financials: BioNeutra Global Corp AI Analysis

Home

Stock

BGACF

Financials

BGACF Financial

BioNeutra Global Corp

0%

$0

At close: Mar 24, 16:00:00 GMT-4

0%

$0

Post-market: Mar 24, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is BGACF?

BioNeutra Global Corp. engages in the in the business of research and development, production, and commercialization of ingredients for nutraceutical, functional, and mainstream foods and beverages. The company is headquartered in Edmonton, Alberta. The company went IPO on 2014-11-05. The Company’s lead product, VitaFiber IMO, is an advanced functional and health food ingredient naturally derived from agricultural products. VitaFiber IMO is naturally sweet and lower in calories than sugar and is a natural source of dietary fiber as it provides low calorie soluble prebiotic fiber for human digestive health. The company produces VitaFiber IMO using its patented production processes that naturally transform starch molecules from agriculture cereal crops, including tapioca, field pea or corn, into the functional health molecules of isomalto-oligosaccharide. VitaFiber IMO is also available for retail purchase across the globe through Amazon.com and Shopify.com. The Company’s customers include a mix of small and medium enterprises.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

BGACF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Revenue	10	11	13	15	24	37
Revenue Growth (YoY)	-9%	-15%	-13%	-38%	-35%	0%
Cost of Revenue	6	7	11	12	20	37
Gross Profit	4	4	2	2	3	0
Selling, General & Admin	5	4	4	4	5	9
Research & Development	0	0	0	0	0	0
Operating Expenses	5	5	4	5	6	10
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	0	-2	-2	-2	-3	-13
Income Tax Expense	0	0	0	0	0	0
Net Income	0	-2	-2	-2	-3	-12
Net Income Growth	-100%	0%	0%	-33%	-75%	-500%
Shares Outstanding (Diluted)	46.44	46.44	46.44	46.44	46.44	46.44
Shares Change (YoY)	-1%	0%	0%	0%	0%	1%
EPS (Diluted)	-0.01	-0.04	-0.06	-0.06	-0.07	-0.26
EPS Growth	-87%	-28%	3%	-24%	-70%	-497%
Free Cash Flow	0	0	0	0	1	0
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	40%	36.36%	15.38%	13.33%	12.5%	0%
Operating Margin	0%	-9.09%	-15.38%	-13.33%	-8.33%	-24.32%
Profit Margin	0%	-18.18%	-15.38%	-13.33%	-12.5%	-32.43%
Free Cash Flow Margin	0%	0%	0%	0%	4.16%	0%
EBITDA	0	0	-1	-1	-1	-7
EBITDA Margin	0%	0%	-7.69%	-6.66%	-4.16%	-18.91%
D&A For EBITDA	0	1	1	1	1	2
EBIT	0	-1	-2	-2	-2	-9
EBIT Margin	0%	-9.09%	-15.38%	-13.33%	-8.33%	-24.32%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Follow-Up Questions

What are BioNeutra Global Corp's key financial statements?



According to the latest financial statement (Form-10K), BioNeutra Global Corp has a total asset of $15, Net loss of $-2

What are the key financial ratios for BGACF?



BioNeutra Global Corp's Current ratio is 0.71, has a Net margin is -18.18, sales per share of $0.23.

How is BioNeutra Global Corp's revenue broken down by segment or geography?



BioNeutra Global Corp largest revenue segment is Syrup, at a revenue of 8,601,929 in the most earnings release.For geography, United States is the primary market for BioNeutra Global Corp, at a revenue of 8,485,700.

Is BioNeutra Global Corp profitable?



no, according to the latest financial statements, BioNeutra Global Corp has a net loss of $-2

Does BioNeutra Global Corp have any liabilities?



yes, BioNeutra Global Corp has liability of 21

How many outstanding shares for BioNeutra Global Corp?



BioNeutra Global Corp has a total outstanding shares of 46.44

BioNeutra Global Corp (BGACF) Financial

BGACF Stock Price Chart